This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, S. T. Articles by Heistad, D. D. Search for Related Content PubMed PubMed Citation Articles by Yang, S. T. Articles by Heistad, D. D.

Hypertension, Vol 22, 150-155, Copyright © 1993 by American Heart Association

ARTICLES

Effects of cilazapril on cerebral vasodilatation in hypertensive rats

ST Yang, FM Faraci and DD Heistad
Department of Pharmacology, University of Iowa College of Medicine, Iowa City 52242.

Endothelium-dependent dilatation of cerebral arterioles is impaired during chronic hypertension. The goal of this study was to determine the effects of an angiotensin converting enzyme inhibitor, cilazapril, on endothelium-dependent dilatation in pial arterioles. Four-month-old Wistar-Kyoto (WKY) rats and stroke-prone spontaneously hypertensive rats (SHRSP) received cilazapril in their drinking water (500 mg/L) for 3 to 6 months. Treatment with cilazapril reduced mean arterial pressure in both WKY rats and SHRSP and had no significant effect on baseline diameter of pial arterioles measured with a cranial window. Responses to bradykinin and A23187, but not to nitroglycerin and adenosine, were impaired in SHRSP. Cilazapril did not affect responses to bradykinin (3 x 10(-7) M) and A23187 (10(-5) M) in WKY rats but significantly increased cerebral vasodilatation in response to bradykinin (52 +/- 4% vs 27 +/- 5%) and A23187 (19 +/- 3% vs 8 +/- 3%) in SHRSP. Cilazapril also tended to increase dilator responses to nitroglycerin and adenosine in SHRSP. In another group of SHRSP, treatment with cilazapril for 4 days produced a moderate reduction in blood pressure and increased cerebral vasodilatation in response to bradykinin, A23187, and adenosine. Topical application of the active form of cilazapril (cilazaprilat) for 40 minutes also increased cerebral vasodilatation in response to bradykinin, A23187, and nitroglycerin in SHRSP. The data indicate that an angiotensin converting enzyme inhibitor enhances cerebral vasodilatation in response to endothelium- dependent agonists in SHRSP and may also increase responses to endothelium-independent agonists.

This article has been cited by other articles:

				J. R. Jennings, M. F. Muldoon, J. Price, I. C. Christie, and C. C. Meltzer Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment Hypertension, July 1, 2008; 52(1): 65 - 71. [Abstract] [Full Text] [PDF]

				S. P. Didion and F. M. Faraci Angiotensin II Produces Superoxide-Mediated Impairment of Endothelial Function in Cerebral Arterioles Stroke, August 1, 2003; 34(8): 2038 - 2042. [Abstract] [Full Text] [PDF]

				J. R. Jennings Autoregulation of Blood Pressure and Thought: Preliminary Results of an Application of Brain Imaging to Psychosomatic Medicine Psychosom Med, May 1, 2003; 65(3): 384 - 395. [Abstract] [Full Text] [PDF]

				J.-M. Chillon and G. L. Baumbach Effects of an Angiotensin-Converting Enzyme Inhibitor and a {beta}-Blocker on Cerebral Arteriolar Dilatation in Hypertensive Rats Hypertension, June 1, 2001; 37(6): 1388 - 1393. [Abstract] [Full Text] [PDF]

				J. Takada, S. Ibayashi, T. Nagao, H. Ooboshi, T. Kitazono, and M. Fujishima Bradykinin Mediates the Acute Effect of an Angiotensin-Converting Enzyme Inhibitor on Cerebral Autoregulation in Rats Stroke, May 1, 2001; 32(5): 1216 - 1219. [Abstract] [Full Text] [PDF]

				H. D. Intengan and E. L. Schiffrin Vasopeptidase Inhibition Has Potent Effects on Blood Pressure and Resistance Arteries in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, June 1, 2000; 35(6): 1221 - 1225. [Abstract] [Full Text] [PDF]

				F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]

				H. Takaba, T. Nagao, S. Ibayashi, T. Kitazono, K. Fujii, and M. Fujishima Altered Cerebrovascular Response to a Potassium Channel Opener in Hypertensive Rats Hypertension, July 1, 1996; 28(1): 143 - 146. [Abstract] [Full Text]

				Y. Hirata, H. Hayakawa, M. Kakoki, A. Tojo, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, M. Hirobe, et al. Nitric Oxide Release From Kidneys of Hypertensive Rats Treated With Imidapril Hypertension, March 1, 1996; 27(3): 672 - 678. [Abstract] [Full Text]

				D. D. Heistad, M. L. Armstrong, G. L. Baumbach, and F. M. Faraci Sick Vessel Syndrome : Recovery of Atherosclerotic and Hypertensive Vessels Hypertension, September 1, 1995; 26(3): 509 - 513. [Abstract] [Full Text]